Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 341-347

  Vlodavsky, Israel ^a   Friedmann, Yael ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN; HEPARAN SULFATE; HEPARANASE; SYNDECAN;

ANGIOGENESIS; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TUMOR VASCULARIZATION;

EID: 0034904048     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13662     Document Type: Review

References (35)

1. Proteoglycans: Structures and interactions
2. Functions of cell surface heparan sulfate proteoglycans
3. Matrix proteoglycans: From molecular design to cellular function
4. Extracellular matrix-bound growth factors, enzymes and plasma proteins
5. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
6. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
7. Cloning and functional expression of a human heparanase gene
8. Human heparanase. Purification, characterization, cloning, and expression
9. Processing of the human heparanase precursor and evidence that the active enzyme is a hererodimer
10. Heparanase, a potent regulator of cell matrix interactions
11. Identification of active-site of the pro-metastatic endoglycisidase heparanase
12. Heparanase: A key enzyme involved in cell invasion
13. Heparanases and tumor metastasis
14. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
15. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases
16. Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation
17. Substrate specificity of heparanases from human hepatoma and platelets
18. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity
19. Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence
20. Cloning and expression profiling of hpa2, a novel mammalian heparanase family member
21. Genomic organization and chromosome localization of the newly identified human heparanase gene
22. Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils
23. Expression of heparanase in normal, dysplastic and neoplastic human colon mucosa and stroma
24. Molecular behavior adapts to context: Heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH
25. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis
26. Heparanase expression in primary and metastatic pancreatic cancer
27. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor κB
28. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase
29. Control of angiogenesis by heparin and other sulfated polysaccharides
30. Heparan sulfate proteoglycans: Heavy hitters in the angiogenesis arena
31. Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor
32. Heparanase as mediator of angiogenesis: Mode of action
33. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
34. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
35. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis